Stocks
Intellia Therapeutics (NTLA) FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| FCF, bln rub | ? | -237.8 | -391.7 | -408.1 | -354.7 | -354.7 | -363.6 | ||
| Changes by years, y/y, % | +344% | +65% | +4% | -13% | 0% | +46.0% | |||
Intellia Therapeutics. FCF, bln rub
Intellia Therapeutics. FCF, changes, %
Intellia Therapeutics. FCF, sum by quarters, bln rub
Intellia Therapeutics (NTLA) FCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| FCF, bln rub | ? | -149.7 | -99.9 | -76.9 | -69.4 | -117.4 | -363.6 | |
| Changes by years, y/y, % | +22% | +69% | -11% | -19% | -22% | |||
| Changes by quarters, q/q, % | +74% | -33% | -23% | -10% | +69% | |||
